drugset / Trial / NCT00834444

Famciclovir 500 mg Tablets Under Non-Fasting Conditions

NCT00834444

Phase 1 Completed 36 enrolled Teva Pharmaceuticals USA
RandomizedCrossoverOpen-labelOther

Summary

The objective of this study is to compare the relative bioavailability of famciclovir 500 mg tablets (Novopharm Limited) with that of FAMVIR® 500 mg tablets (Novartis) in healthy adult subjects under non-fasting conditions.

Timeline

Start
2004-08
Primary completion
2004-09
Completion
2004-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Famciclovir Small molecule 500 mg

Indications

No indication recorded.